Cite
Steiner G, Marban-Doran C, Langer J, et al. Correction to "Enabling Routine MHC-II-Associated Peptide Proteomics for Risk Assessment of Drug-Induced Immunogenicity". J Proteome Res. 2020;20(1):1103doi: 10.1021/acs.jproteome.0c00716.
Steiner, G., Marban-Doran, C., Langer, J., Pimenova, T., Duran-Pacheco, G., Sauter, D., Langenkamp, A., Solier, C., Singer, T., Bray-French, K., & Ducret, A. (2021). Correction to "Enabling Routine MHC-II-Associated Peptide Proteomics for Risk Assessment of Drug-Induced Immunogenicity". Journal of proteome research, 20(1), 1103. https://doi.org/10.1021/acs.jproteome.0c00716
Steiner, Guido, et al. "Correction to "Enabling Routine MHC-II-Associated Peptide Proteomics for Risk Assessment of Drug-Induced Immunogenicity"." Journal of proteome research vol. 20,1 (2021): 1103. doi: https://doi.org/10.1021/acs.jproteome.0c00716
Steiner G, Marban-Doran C, Langer J, Pimenova T, Duran-Pacheco G, Sauter D, Langenkamp A, Solier C, Singer T, Bray-French K, Ducret A. Correction to "Enabling Routine MHC-II-Associated Peptide Proteomics for Risk Assessment of Drug-Induced Immunogenicity". J Proteome Res. 2021 Jan 01;20(1):1103. doi: 10.1021/acs.jproteome.0c00716. Epub 2020 Oct 07. PMID: 33025787.
Copy
Download .nbib